Allogenic Adipose MSC-Exos
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogenic Adipose MSC-Exos, covering 2021-06-25 to 2021-06-25. Get the full timeline:
Most recent: Clinical Trial Update: the Safety and the Efficacy Evaluation of Allogenic Adipose MSC-Exos in Patients With Alzheimer's Disease [Phase 1, Phase 2]